Asia-Pacific

Axa strengthens private equity board

The French insurer is acknowledging the importance of its private equity operations in pacific-asia region with the promotion of Christophe Florin, its local managing director.

Apollo to list on Goldman exchange

Apollo will reportedly become the second major alternative asset manager to list a portion of its management company on Goldman’s private exchange. The private float is expected to follow sales of minority stakes to Abu Dhabi and possibly CalPERS.

Baring Asia completes first deal in Japan

Baring Asia has completed its first buyout in Japan, a market it has been targeting since it closed a $490 million fund last year. The firm’s successes elsewhere in the region are beginning to attract the attention of investors.

Apollo and Abu Dhabi disagree about 10% stake’s $1.5bn value(3)

Apollo Management is reportedly in a dispute over the valuation of the firm in its attempt to sell a 10 percent stake to the Abu Dhabi Investment Authority.

Blackstone finds room for $26bn buyout of Hilton(3)

Already the owner of 100,000 hotel rooms globally, the buyout firm is adding another 480,000 to its portfolio through the acquisition of legendary hotel group Hilton.

Blackstone finds room for $26bn buyout of Hilton(2)

Already the owner of 100,000 hotel rooms globally, the buyout firm is adding another 480,000 to its portfolio through the acquisition of legendary hotel group Hilton.

CDC expands with four appointments(2)

Four directors have been appointed at UK government-backed emerging markets fund of funds CDC, as the business continues to diversify its investment activities.

Clearwater closes third Asia fund on $900m(2)

The New York-based firm’s latest fund closed on nearly twice its initial target.

Blackstone finds room for $26bn buyout of Hilton

Already the owner of 100,000 hotel rooms globally, the buyout firm is adding another 480,000 to its portfolio through the acquisition of legendary hotel group Hilton.

Clearwater closes third Asia fund on $900m

The New York-based firm’s latest fund closed on nearly twice its initial target.